Aker BioMarine AS

BST:1PG Stock Report

Market Cap: €484.9m

Aker BioMarine Management

Management criteria checks 4/4

Aker BioMarine's CEO is Matts Johansen, appointed in Jul 2015, has a tenure of 9.5 years. total yearly compensation is $688.81K, comprised of 61% salary and 39% bonuses, including company stock and options. directly owns 1.25% of the company’s shares, worth €6.06M. The average tenure of the management team and the board of directors is 3.3 years and 3.8 years respectively.

Key information

Matts Johansen

Chief executive officer

US$688.8k

Total compensation

CEO salary percentage61.0%
CEO tenure9.5yrs
CEO ownership1.2%
Management average tenure3.3yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Matts Johansen's remuneration changed compared to Aker BioMarine's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$3m

Jun 30 2024n/an/a

-US$11m

Mar 31 2024n/an/a

-US$8m

Dec 31 2023US$689kUS$420k

-US$9m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$300k

Mar 31 2023n/an/a

US$14m

Dec 31 2022US$410kUS$401k

US$10m

Sep 30 2022n/an/a

US$1m

Jun 30 2022n/an/a

US$10m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021US$467kUS$459k

-US$8m

Sep 30 2021n/an/a

US$3m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$630kUS$420k

-US$5m

Sep 30 2020n/an/a

-US$26m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$18m

Dec 31 2019US$660kUS$450k

-US$24m

Compensation vs Market: Matts's total compensation ($USD688.81K) is about average for companies of similar size in the German market ($USD975.18K).

Compensation vs Earnings: Matts's compensation has been consistent with company performance over the past year.

CEO

Matts Johansen (48 yo)

9.5yrs

Tenure

US$688,813

Compensation

Mr. Matts Johansen serves as an Advisor at RunwayFBU AS. He has been Chief Executive Officer at Aker BioMarine ASA since July 1, 2015. He has been Chief Operating Officer of Aker Biomarine Antarctic AS sin...

Leadership Team

NamePositionTenureCompensationOwnership
Matts Johansen
Chief Executive Officer9.5yrsUS$688.81k1.25%
€ 6.1m
Katrine Klaveness
Chief Financial Officer7yrsUS$378.29kno data
Hege Spaun
Chief Officer People & Communicationless than a yearUS$221.24kno data
Trond Smedsrud
Chief Executive Officer of Emerging Businessno dataUS$284.93kno data
Tone Lorentzen
Chief Operating Officer of Human Health Ingredientsno dataUS$339.88kno data
Simon Seward
Chief Executive Officer of Human Health Ingredients3yrsUS$306.31kno data
Seth French
Chief Executive Officer of Lang Pharma Nutrition Inc3.3yrsUS$834.94kno data
Christopher Robin Vinter
Vice President of IR & Corporate Financeno datano datano data
Lise Wiger
Financial Controllerno datano datano data

3.3yrs

Average Tenure

Experienced Management: 1PG's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kjell Røkke
Deputy Directorno datano datano data
Frank Reite
Directorno dataUS$30.76kno data
Anne Harris
Independent Director3.8yrsUS$48.75kno data
Ola Snøve
Chairman11yrsUS$70.05k0.98%
€ 4.7m
Cilia Indahl
Director3.8yrsUS$30.76kno data
Sindre Skjong
Employee Representative Director5.4yrsno datano data
Kimberly Mathisen
Director2.8yrsUS$30.76k0.0046%
€ 22.1k
Kristin Holmgren
Employee Representative Director1.6yrsno data0.0040%
€ 19.2k
Thomas Rokke
Employee Representative Director1.6yrsno datano data

3.8yrs

Average Tenure

53yo

Average Age

Experienced Board: 1PG's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 04:08
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aker BioMarine AS is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Ole-Andreas KrohnDNB Markets
Ola TrovatnDNB Markets